Skip to main content

Centene Corp

Exchange: NYSESector: HealthcareIndustry: Healthcare Plans

Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.

Did you know?

Earnings per share grew at a 20.1% CAGR.

Current Price

$53.34

-0.65%

GoodMoat Value

$1901.11

3464.1% undervalued
Profile
Valuation (TTM)
Market Cap$26.23B
P/E-4.07
EV$13.21B
P/B1.31
Shares Out491.77M
P/Sales0.13
Revenue$198.10B
EV/EBITDA

Centene Corp (CNC) Company Profile

GoodMoat Analysis

Based on data as of March 26, 2026

Centene Corp is a major health insurer focused on government-sponsored programs like Medicaid and Medicare, operating in a complex, regulated market. While its scale and regulatory expertise provide a potential moat, the current financial data shows significant losses and negative profitability, raising red flags for value investors.

Read full analysis
Centene Corp (CNC) is a managed healthcare enterprise, primarily administering government-sponsored health insurance programs like Medicaid for low-income families and Medicare for seniors. Its customers are the state and federal governments that contract with it to manage these plans, and the millions of individual members enrolled. Its potential moat, assessed via the GoodMoat framework, likely stems from regulatory barriers and scale privilege. Operating in a highly regulated sector with complex contracting requires significant expertise and infrastructure, creating high switching costs for its government clients. Its large member base provides scale advantages in negotiating with healthcare providers. However, the current financial data presents significant concerns. The company shows negative profitability with an operating margin of -3.9% and a deeply negative ROE of -33.4%, which is far below the quality threshold of >15-20%. The negative P/E of -2.41 and negative EPS of -$13.53 confirm this. These metrics align with High Confidence Red Flags for margin compression and potentially execution risk. A value investor might be interested in the high free cash flow yield of 26.9% and revenue growth of 23.2% YoY, but would need to investigate whether the negative profits are a temporary issue or a structural problem before the business could pass the Moat & Quality Gate for further analysis. The substantial debt-to-equity ratio of 0.87 also warrants close scrutiny. Analysis based on data as of 2024-05-15.

CNC Company Information

Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives.

The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals.

Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.

Sector

Healthcare

Industry

Healthcare Plans

Exchange

NYSE

Country

Missouri, USA

CNC Key Officers

Key officers data coming soon

CNC Company Profile

Centene Corp (CNC) is a Healthcare company in the Healthcare Plans industry. It trades on NYSE. The company is based in Missouri, USA.

Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.

Market cap is $26.23B. There are 491.8M shares outstanding.

See the full Centene Corp profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if CNC is a good investment.